ROBINS LAUNCHING REFORMULATED DIMETAPP OTC ON JUNE 3, COMPANY ANNOUNCES AT ITS ANNUAL MEETING; LATEST IN-LICENSE IS BAYER ANTIHYPERTENSIVE MUZOLAMINE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".